Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Immunome Inc IMNM

Immunome, Inc. is a biotechnology company engaged in developing targeted cancer therapies. The Company's portfolio pursues each target with a modality appropriate to its biology, including immunotherapies, radioligand therapies and Antibody-Drug Conjugates (ADCs). Its memory B cell hybridoma technology allows for the screening and functional characterization of novel antibodies and targets. Its... see more

NDAQ:IMNM - Post Discussion

Immunome Inc > Over $13M Bet On ProFrac Holding? Check Out These 4 Stocks I
View:
Post by whytestocks on May 22, 2024 11:00am

Over $13M Bet On ProFrac Holding? Check Out These 4 Stocks I

Just In: $IMNM Over $13M Bet On ProFrac Holding? Check Out These 4 Stocks Insiders Are Buying | BenzingaAlthough U.S. stocks closed higher on Tuesday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidenc...IMNM - Over $13M Bet On ProFrac Holding? Check Out These 4 Stocks Insiders Are Buying | Benzinga
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities